Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totaling 246 shares, a growth of ∞ from the April 30th total of 0 shares. Based on an average trading volume of 186 shares, the days-to-cover ratio is presently 1.3 days.
Hikma Pharmaceuticals Price Performance
Shares of OTCMKTS:HKMPY remained flat at $39.00 during midday trading on Wednesday. 169 shares of the stock were exchanged, compared to its average volume of 1,537. The firm has a fifty day moving average price of $36.98 and a two-hundred day moving average price of $39.40. Hikma Pharmaceuticals has a 1 year low of $31.80 and a 1 year high of $56.20.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- HIVE Earnings Highlight AI Ambitions Beyond Bitcoin Mining
- Microsoft Build 2026 Is Really Just One Big AI Stress Test
- Slice of the Pie: Why Yum’s Deal Lifts QSR
- 3 Most Upgraded Stocks Last Month According to MarketBeat
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
